|
Friday, December 6, 2024, San Diego, California, 7:30 AM – 9:30 AM PT (10:30 AM – 12:30 PM ET)
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic LeukemiaA CME Friday Satellite Symposium and Webcast Preceding the 66th ASH Annual Meeting
Program Schedule — Pacific Time
7:00 AM – 7:30 AM — Registration and Breakfast 7:30 AM – 9:30 AM — Educational Meeting Location Manchester Grand Hyatt San Diego 1 Market Place San Diego, California Meeting Room Seaport E-H (Second Level) This event will also be webcast live. Please see Registration tab for details. Faculty
Farrukh T Awan, MD Professor of Internal Medicine Director of Lymphoid Malignancies Program Harold C Simmons Comprehensive Cancer Center The University of Texas Southwestern Medical Center Dallas, Texas Bita Fakhri, MD, MPH Assistant Professor of Medicine (Hematology) Stanford University School of Medicine Stanford, California Kerry A Rogers, MD Associate Professor Division of Hematology The Ohio State University Columbus, Ohio William G Wierda, MD, PhD Jane and John Justin Distinguished Chair in Leukemia Research in Honor of Dr Elihu Estey Section Chief, Chronic Lymphocytic Leukemia Center Medical Director Department of Leukemia Division of Cancer Medicine Executive Medical Director Inpatient Medical Services The University of Texas MD Anderson Cancer Center Houston, Texas Moderator Jeff Sharman, MD Medical Director of Hematology Research US Oncology Network Sarah Cannon Research Institute Willamette Valley Cancer Institute and Research Center Eugene, Oregon This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, BeiGene Ltd, and Lilly.
Program Schedule — Pacific Time
7:00 AM – 7:30 AM — Registration and Breakfast 7:30 AM – 9:30 AM — Educational Meeting Discussion Topics
Target Audience
CE Credit FACULTY — The following faculty reported relevant financial relationships with ineligible entities: Dr Awan — Consulting Agreements: AbbVie Inc, Adaptive Biotechnologies Corporation, ADC Therapeutics, AstraZeneca Pharmaceuticals LP, BeiGene Ltd, Bristol Myers Squibb, Caribou Biosciences Inc, DAVA Oncology, Genmab US Inc, Incyte Corporation, Kite, A Gilead Company, Loxo Oncology Inc, a wholly owned subsidiary of Eli Lilly & Company; Contracted Research: Pharmacyclics LLC, an AbbVie Company; Data and Safety Monitoring Boards/Committees: Ascentage Pharma, AstraZeneca Pharmaceuticals LP. Dr Fakhri — Advisory Committees: AbbVie Inc, Adaptive Biotechnologies Corporation, AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, Genentech, a member of the Roche Group, Loxo Oncology Inc, a wholly owned subsidiary of Eli Lilly & Company; Contracted Research: AbbVie Inc, Genmab US Inc, Loxo Oncology Inc, a wholly owned subsidiary of Eli Lilly & Company; Speakers Bureau: Loxo Oncology Inc, a wholly owned subsidiary of Eli Lilly & Company. Dr Rogers — Advisory Committees: AstraZeneca Pharmaceuticals LP, Janssen Biotech Inc; Consulting Agreements: AbbVie Inc, Alpine Immune Sciences, BeiGene Ltd, Genentech, a member of the Roche Group, Loxo Oncology Inc, a wholly owned subsidiary of Eli Lilly & Company, Pharmacyclics LLC, an AbbVie Company; Contracted Research: AbbVie Inc, AstraZeneca Pharmaceuticals LP, Genentech, a member of the Roche Group, Loxo Oncology Inc, a wholly owned subsidiary of Eli Lilly & Company, Novartis. Dr Wierda — Consulting Agreements: BeiGene Ltd, Numab Therapeutics AG; Contracted Research: AbbVie Inc, Acerta Pharma — A member of the AstraZeneca Group, Bristol Myers Squibb, Cyclacel Pharmaceuticals Inc, Genentech, a member of the Roche Group, Gilead Sciences Inc, GSK, Janssen Biotech Inc, Juno Therapeutics, a Celgene Company, Kite, A Gilead Company, Loxo Oncology Inc, a wholly owned subsidiary of Eli Lilly & Company, Novartis, Nurix Therapeutics Inc, Oncternal Therapeutics, Pharmacyclics LLC, an AbbVie Company; Nonrelevant Financial Relationships: National Comprehensive Cancer Network (Chair, CLL), Support by the NIH/NCI under award number P30 CA016672 and use of MD Anderson Cancer Center Support Grant (CCSG) shared resources. MODERATOR — Dr Sharman — Consulting Agreements: AbbVie Inc, AstraZeneca Pharmaceuticals LP, BeiGene Ltd, Bristol Myers Squibb, Genentech, a member of the Roche Group, Merck, Novartis, Pharmacyclics LLC, an AbbVie Company. Research To Practice CME Planning Committee Members, Staff and Reviewers — Planners, scientific staff and independent reviewers for Research To Practice have no relevant conflicts of interest to disclose. SupportersThis activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, BeiGene Ltd, and Lilly. Manchester Grand Hyatt San Diego
This activity is intended for hematologists, medical oncologists and other healthcare providers involved in the treatment of chronic lymphocytic leukemia.
There is no fee to participate in this hybrid event. In order to attend the in-person symposium in San Diego, you must also be registered to attend the ASH 2024 Annual Meeting. Preregistration (below) is required as seating is limited for this program. IN-PERSON Registration for clinicians in practice/healthcare professionals
I am a practicing physician, fellow, nurse or other healthcare provider involved in the treatment of cancer. IN-PERSON Registrationfor clinicians » IN-PERSON Registration for other/industry professionals*
Please note, a limited number of seats are available to other/industry professionals on a first come, first served basis. IN-PERSON Registrationfor nonclinicians »
* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
LIVE WEBCAST Registration for all professionals
Please note, we will stream this event over Zoom. After registering you will receive a separate confirmation from Zoom with the viewing instructions. REGISTRATION FOR WEBCAST »Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at
Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating and meal service, please check in at our onsite registration desk at least 15 minutes before the start of the meeting. We cannot guarantee seating after the start of the program.Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational offerings. Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153. If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com, or call (800) 233-6153. |